Live Breaking News & Updates on Journey Medical Corp

Stay updated with breaking news from Journey medical corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying - Journey Medical (NASDAQ:DERM), Citizens (NYSE:CIA)

The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. ....

United States , James Keith Morgan , Thomasj Shaw , Journey Medical Corp , Citizens Inc , Retractable Technologies Inc , Dow Jones , Journey Medical Corporation , Retractable Technologies , Retractable Technologies Does , Jon Stenberg , Citizens Does , Walgreens Earnings Are Imminent , Journey Medical , Journey Medical Does ,

Journey Medical Submits NDA For DFD-29 To FDA For Treatment Of Rosacea In Adults

Pharmaceutical company Journey Medical Corp. (DERM) announced Friday that the Company has submitted a New Drug Application or NDA, to the U.S. Food and Drug Administration or FDA, seeking approval for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the treatment of inflammatory lesions and erythema of rosacea in adults. ....

Reddy Laboratories Ltd , Drug Administration , Journey Medical Corp , Journey Medical , New Drug Application , Us Food And Drug Administration , Journey Medical , Fd 29 , Harmaceutical Company Journey Medical , Minocycline Hydrochloride ,

Journey Medical Reports Positive Results From Phase 3 Trials With DFD-29; Plans NDA In H2

Journey Medical Corp. (DERM) reported positive topline results from the two Phase 3 double-blind, parallel-group, active-comparator and placebo-controlled clinical trials, Minocycline Versus Oracea in Rosacea-1 or MVOR-1 and Minocycline Versus Oracea in Rosacea-2 or MVOR-2, evaluating Minocycline Hydrochloride Modified Release Capsules, 40 mg for the treatment of moderate-to-severe papulopustular rosacea in adults. ....

Journey Medical Corp , More Such Health News , Journey Medical , Minocycline Versus Oracea , Global Assessment , Hydrochloride Modified Release Capsules , Marketing Authorization Application , Journey Medical ,